- Home
- EUDA vs ATOS Comparison
EUDA vs ATOS Comparison
Compare EUDA & ATOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EUDA
- ATOS
- Stock Information
- Founded
- EUDA 2021
- ATOS 2009
- Country
- EUDA Singapore
- ATOS United States
- Employees
- EUDA N/A
- ATOS N/A
- Industry
- EUDA Blank Checks
- ATOS Biotechnology: Pharmaceutical Preparations
- Sector
- EUDA Finance
- ATOS Health Care
- Exchange
- EUDA Nasdaq
- ATOS Nasdaq
- Market Cap
- EUDA 111.5M
- ATOS 107.2M
- IPO Year
- EUDA N/A
- ATOS 2012
- Fundamental
- Price
- EUDA $2.54
- ATOS $0.78
- Analyst Decision
- EUDA
- ATOS Strong Buy
- Analyst Count
- EUDA 0
- ATOS 3
- Target Price
- EUDA N/A
- ATOS $6.17
- AVG Volume (30 Days)
- EUDA 80.9K
- ATOS 1.3M
- Earning Date
- EUDA 12-19-2023
- ATOS 08-12-2025
- Dividend Yield
- EUDA N/A
- ATOS N/A
- EPS Growth
- EUDA N/A
- ATOS N/A
- EPS
- EUDA N/A
- ATOS N/A
- Revenue
- EUDA $4,011,005.00
- ATOS N/A
- Revenue This Year
- EUDA $212.19
- ATOS N/A
- Revenue Next Year
- EUDA $254.35
- ATOS N/A
- P/E Ratio
- EUDA N/A
- ATOS N/A
- Revenue Growth
- EUDA 8.22
- ATOS N/A
- 52 Week Low
- EUDA $2.20
- ATOS $0.55
- 52 Week High
- EUDA $6.30
- ATOS $1.66
- Technical
- Relative Strength Index (RSI)
- EUDA 29.29
- ATOS 42.24
- Support Level
- EUDA $2.50
- ATOS $0.81
- Resistance Level
- EUDA $2.80
- ATOS $0.80
- Average True Range (ATR)
- EUDA 0.22
- ATOS 0.04
- MACD
- EUDA -0.04
- ATOS -0.01
- Stochastic Oscillator
- EUDA 29.57
- ATOS 7.50
About EUDA EUDA Health Holdings Limited
EUDA Health Holdings Ltd is a non-invasive healthcare company across Southeast Asia and China. The Company has two reportable segments: property management services and holistic wellness consumer products and services. Key revenue is generated from property management services that include common area property management services that contain cleaning, landscaping, public facilities maintenance and other traditional services and also include security property management services provided to all tenants and property owners.
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.